Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00813761 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the Long-Term Effects of Contact Lens Care Systems
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 473
- Enrollment target
NCT00813761: Completed NA study, sponsored by Johnson & Johnson Vision Care.
NCT00813761 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 473 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00813761, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 473 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two marketed contact lens care solutions in regards to comfort and ocular health.
Primary Outcome
Average hours per day that contact lens were worn.
Interventions
- DEVICE ReNu MultiPlus Multi-Purpose Solution
- DEVICE O2Optix contact lens
- DEVICE Proclear contact lens
- DEVICE Clear Care Cleaning and Disinfecting Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 473 participants |
| Start Date | 2008-09-01 |
| Est. Completion | 2009-08-01 |
| Phase | NA |
What the finished NCT00813761 record still lists
NCT00813761 is an interventional study that assigns participants to a tested intervention. The registered 473 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 4 interventions - of which ReNu MultiPlus Multi-Purpose Solution is the first listed.
NCT00813761 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00813761 about?
NCT00813761 is a clinical study titled "Clinical Evaluation of the Long-Term Effects of Contact Lens Care Systems". The purpose of this study is to compare two marketed contact lens care solutions in regards to comfort and ocular health.
What is the current status of trial NCT00813761?
This trial is currently completed. It is a NA study. The enrollment target is 473 participants. The study started on 2008-09-01. Estimated completion is 2009-08-01.
What interventions are being tested in trial NCT00813761?
The interventions under investigation include: ReNu MultiPlus Multi-Purpose Solution (DEVICE), O2Optix contact lens (DEVICE), Proclear contact lens (DEVICE), Clear Care Cleaning and Disinfecting Solution (DEVICE).
Who is sponsoring clinical trial NCT00813761?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00813761's enrollment target sits among peer trials
473 220th of 2000 higher than 1,781 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05624996 · 474 participants · Phase 3
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- NCT06051695 · 474 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- NCT06632977 · 474 participants · Phase 2
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- NCT06375083 · 472 participants · Phase 2
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI